Evofem Biosciences announces cost reduction measures
Evofem Biosciences, Inc., announced it has implemented measures to lower its operating expenses, with the goal of reaching cash flow break even by year-end 2023.
These measures include a 39% reduction of payroll expenses through a combination of: i.Salary cuts for certain employees, including a 40% reduction in Chief Executive Officer compensation and a 20% reduction in pay for other continuing members of the executive team vs. prior year levels; ii. Consolidation of three sales territories; iii. Elimination of eight office and management positions, including the Chief Commercial Officer role, effective March 17, 2023.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins